
### [NCIT:C129445](http://purl.obolibrary.org/obo/NCIT_C129445)
**Label:** Medulloblastoma, Non-WNT/Non-SHH, Group 3

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C36593](http://purl.obolibrary.org/obo/NCIT_C36593) (Increased NFkappaB Pathway Activation))) 55.00%
- Thing 53.58%
- [NCIT:C82326](http://purl.obolibrary.org/obo/NCIT_C82326) (Sonic Hedgehog/Patch Pathway Activated) 52.50%
- [NCIT:C78303](http://purl.obolibrary.org/obo/NCIT_C78303) (Gait Disturbance) 52.50%
- [NCIT:C3834](http://purl.obolibrary.org/obo/NCIT_C3834) (Ataxic Gait) 52.50%
- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 52.50%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 52.50%
- [NCIT:C34661](http://purl.obolibrary.org/obo/NCIT_C34661) (Headache) 52.50%
- [NCIT:C3442](http://purl.obolibrary.org/obo/NCIT_C3442) (Vomiting) 52.50%
- [NCIT:C28082](http://purl.obolibrary.org/obo/NCIT_C28082) (Grade 4) 52.50%
- [NCIT:C129437](http://purl.obolibrary.org/obo/NCIT_C129437) (WNT Pathway Activated) 52.50%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) 45.82%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 45.82%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 45.82%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 45.82%


